ArticleBMC geriatrics2025
Frailty in older adults with chronic obstructive pulmonary disease: preliminary findings of prevalence and care priorities.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFrailty is prevalent among older adults and exerts a significant impact on their quality of life. The present study aims to analyze the current status of frailty in older adults with chronic obstructive pulmonary disease (COPD) as well as its influencing factors, thereby providing evidence-based support for clinical treatment and nursing practices.
methodsOlder patients with COPD admitted to our hospital from January 2024 to April 2025 were included in this study. Patients with concurrent asthma or interstitial lung disease (ILD) were excluded to minimize confounding. Clinical data were collected, and frailty was assessed within 24 h of admission (when patients were clinically stable). Correlation analysis and multivariate logistic regression analysis were conducted to identify the influencing factors of frailty in older patients with COPD. Clinical trial number: not applicable.
resultsA total of 224 older adults with COPD were enrolled in the study, among whom 68 (30.36%) were robust (normal state), 84 (37.50%) were pre-frail, and 72 (32.14%) met the criteria for frailty. Correlation analysis showed that age(r = 0.602), GOLD stage(r = 0.596), and COPD duration(r = 0.558), serum interleukin-6(r = 0.534) and serum hemoglobin concentration(r=-0.579) were correlated with the frailty of older adults with COPD (all p < 0.05). Multivariate logistic regression analysis indicated that age (OR = 1.809, 95%CI: 1.233 ~ 2.195), GOLD stage (OR = 2.456, 95%CI: 1.977 ~ 2.850), and COPD duration (OR = 1.768, 95%CI: 1.104 ~ 1.993), serum interleukin-6 (OR = 1.454, 95%CI: 1.113 ~ 2.006) and serum hemoglobin concentration (OR = 0.675, 95%CI: 0.225 ~ 0.901) were the influencing factors of the frailty of older adults with COPD (all p < 0.05).
conclusionThe prevalence of frailty is relatively high in older adults with COPD. Clinically, targeted interventions and nursing care should be carried out for factors that influence the frailty in older adults with COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.